Clinical and immunologic progression in HIV-infected US women before and after the introduction of highly active antiretroviral therapy.

Objective: To examine factors associated with clinical and immunologic HIV disease progression in a cohort of US women.

Design: Analysis of data from a prospective, longitudinal, case-control study of HIV-infected women followed every 6 months for 7 years.

Setting: Four urban clinical centers in the United States.